{"id":3067,"date":"2016-05-17T06:30:00","date_gmt":"2016-05-17T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/"},"modified":"2016-05-17T06:30:00","modified_gmt":"2016-05-17T06:30:00","slug":"conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/","title":{"rendered":"Conference call regarding information on the offer made to Vivoline\u2019s shareholders"},"content":{"rendered":"
Invitation to attend XVIVO Perfusion\u2019s conference call regarding information on the offer made to Vivoline\u2019s shareholders. The presentation will be held in Swedish.<\/strong><\/div>\n<\/p>\n

This press release may not, directly nor indirectly, be distributed in or to, Australia, Hong Kong, Japan, Canada, New Zeeland, South Africa or the U.S or in any other country where making of the Offer, distribution of this press release or acceptance of the Offer would be contrary to applicable laws or rules or would require further offering documentation or registration or any other measures in addition to what is required by Swedish law.<\/span><\/em><\/p>\n

Time: <\/span>Thursday<\/span>, May 19, 2016 at 2.00 p.m. CET<\/span><\/span><\/p>\n

Registration can preferably be done in advance under the following link: <\/span><\/p>\n

https:\/\/engage.vevent.com\/rt\/xvivoperfusion\/index.jsp?seid=63<\/span><\/p>\n

<\/span><\/span><\/p>\n

or shortly before time of the conference starts on:<\/span>
<\/span>Sweden dial in number: +46 (0)<\/span>8-503\u00a0364 34
International dial in number: +44 (0) 1452 555566
Conference name: XVIVO Perfusion, conference ID: <\/span>13703098<\/span><\/span><\/p>\n

Participants from XVIVO Perfusion:
Magnus Nilsson, CEO
Christoffer Rosenblad, CFO<\/span><\/p>\n

Shortly before the conference call, slides will be available at the company web page, <\/span>www.xvivoperfusion.com\/corporate\/<\/span>.<\/span><\/p>\n

May 17, 2016<\/span>
Gothenburg
XVIVO Perfusion AB (publ)<\/span><\/p>\n


<\/span><\/em><\/p>\n

\n

For further information please contact:
<\/span>
Christoffer Rosenblad, CFO, +1 720 616 2101,\u00a0christoffer.rosenblad@xvivoperfusion.com<\/span><\/p>\n

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Invitation to attend XVIVO Perfusion\u2019s conference call regarding information on the offer made to Vivoline\u2019s shareholders. The presentation will be…<\/p>\n","protected":false},"template":"","class_list":["post-3067","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"\nConference call regarding information on the offer made to Vivoline\u2019s shareholders - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conference call regarding information on the offer made to Vivoline\u2019s shareholders - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Invitation to attend XVIVO Perfusion\u2019s conference call regarding information on the offer made to Vivoline\u2019s shareholders. The presentation will be...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\\\/\",\"name\":\"Conference call regarding information on the offer made to Vivoline\u2019s shareholders - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2016-05-17T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conference call regarding information on the offer made to Vivoline\u2019s shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conference call regarding information on the offer made to Vivoline\u2019s shareholders - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/","og_locale":"en_US","og_type":"article","og_title":"Conference call regarding information on the offer made to Vivoline\u2019s shareholders - XVIVO","og_description":"Invitation to attend XVIVO Perfusion\u2019s conference call regarding information on the offer made to Vivoline\u2019s shareholders. The presentation will be...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/","name":"Conference call regarding information on the offer made to Vivoline\u2019s shareholders - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2016-05-17T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-regarding-information-on-the-offer-made-to-vivolines-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Conference call regarding information on the offer made to Vivoline\u2019s shareholders"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}